Micro-RNAs: a new mechanism negatively regulating B cell responses in the elderly

Micro-RNA:负向调节老年人 B 细胞反应的新机制

基本信息

项目摘要

DESCRIPTION (provided by applicant): Aging generates a decline in the ability of the individual to mount protective immune responses. The aged immune system also negatively impacts other important systems, such as the cardiac and nervous systems, by contributing to increased inflammation. The aged immune system not only impacts the quality of life of the individual but also the ability to be protected from infectious agents and cancers. We have shown that aging is associated with autonomous defects in B cells which are important for optimal health because they produce antibodies necessary for responses to vaccines and infectious diseases as well as other functions. These defects/biomarkers include: immunoglobulin (Ig) class switch recombination (CSR), activation-induced cytidine deaminase (AID) and the transcription factor E47. AID is necessary for CSR, the process that generates protective antibodies, and is a good measure of B cell function. We hypothesize that a mechanism for the aged impairment in B cell function, for which we have preliminary data, is that microRNA (miR)-155, miR-16 and other miRs are significantly higher in aged as compared with young adult unstimulated human B cells, making them "refractory" to further stimulation with the result of lower levels of AID induced after B cell stimulation. The objectives of this proposal are to identify miRs up-regulated in unstimulated B cells from elderly individuals, characterize the molecular pathways for their up-regulation as well as their mechanism of action, and begin to correct these defects by designing oligonucleotides which target these miRs. We propose to sort subsets of B cells, perform a miR microarray and correlate levels of the most increased miRs with AID. In the second aim we will identify molecular mechanisms for increases of particular miRs in aged B cells as well as for particular miRs down-regulating AID. In the third aim we will evaluate if lower in vitro CSR can be "rescued" by adding oligonucleotides blocking particular miR function (antagomirs) to B cell cultures. The experiments proposed in this grant offer an innovative approach to further characterize mechanisms which decrease B cell responses in elderly individuals. These studies should contribute to development of effective therapeutic strategies to protect elderly individuals from diseases typical of old age.
描述(由申请人提供):衰老会导致个人安装保护性免疫反应的能力下降。老年免疫系统还通过增加炎症来对其他重要系统(例如心脏和神经系统)产生负面影响。老年免疫系统不仅会影响个人的生活质量,而且还影响了免受感染剂和癌症的保护能力。我们已经表明,衰老与B细胞中的自主缺陷有关,这对于最佳健康很重要,因为它们产生了对疫苗和传染病以及其他功能的反应所必需的抗体。这些缺陷/生物标志物包括:免疫球蛋白(IG)类开关重组(CSR),激活诱导的胞苷脱氨酶(AID)和转录因子E47。辅助是CSR所必需的,CSR是生成保护性抗体的过程,并且是B细胞功能的良好量度。我们假设,您具有初步数据的B细胞功能中老化损伤的机制是,与年轻的成人未刺激的人类B细胞相比,MicroRNA(miR)-155,miR-16和其他miR在老年人中显着更高,使其“折射”以较低的辅助剂量刺激了B细胞刺激后,使其“使其”进一步刺激。该提案的目标是识别来自老年人的未刺激的B细胞中上调的miR,表征其上调的分子途径及其作用机理,并开始通过设计针对这些miR的寡核苷酸来纠正这些缺陷。我们建议对B细胞的子集进行排序,执行miR微阵列,并将MIR的最大水平与AID相关。在第二个目标中,我们将确定年龄B细胞中特定MIR的增加以及特定的MIR下调辅助的分子机制。在第三个目的中,我们将通过在B细胞培养物中添加寡核苷酸(Antagomirs)来评估是否可以“营救”较低的体外CSR。该赠款中提出的实验提供了一种创新的方法,可以进一步表征机制,从而降低了老年人的B细胞反应。这些研究应有助于制定有效的治疗策略,以保护老年人免受典型的老年疾病。

项目成果

期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aging of the immune system: Focus on inflammation and vaccination.
  • DOI:
    10.1002/eji.201546178
  • 发表时间:
    2016-10
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Pinti, Marcello;Appay, Victor;Campisi, Judith;Frasca, Daniela;Fulop, Tamas;Sauce, Delphine;Larbi, Anis;Weinberger, Birgit;Cossarizza, Andrea
  • 通讯作者:
    Cossarizza, Andrea
Immunophenotyping of Human B Lymphocytes in Blood and in Adipose Tissue.
血液和脂肪组织中人 B 淋巴细胞的免疫表型分析。
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BONNIE B. BLOMBERG其他文献

BONNIE B. BLOMBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BONNIE B. BLOMBERG', 18)}}的其他基金

The Aging Immune System: Mechanisms and Restoration
衰老的免疫系统:机制与恢复
  • 批准号:
    8911499
  • 财政年份:
    2015
  • 资助金额:
    $ 23.03万
  • 项目类别:
Aging and the immune system
衰老与免疫系统
  • 批准号:
    8529951
  • 财政年份:
    2013
  • 资助金额:
    $ 23.03万
  • 项目类别:
Micro-RNAs: a new mechanism negatively regulating B cell responses in the elderly
Micro-RNA:负向调节老年人 B 细胞反应的新机制
  • 批准号:
    8509930
  • 财政年份:
    2013
  • 资助金额:
    $ 23.03万
  • 项目类别:
Molecular mechanisms for TNF-mediated inhibition of B lymphocyte function
TNF介导的B淋巴细胞功能抑制的分子机制
  • 批准号:
    8519286
  • 财政年份:
    2012
  • 资助金额:
    $ 23.03万
  • 项目类别:
Molecular mechanisms for TNF-mediated inhibition of B lymphocyte function
TNF介导的B淋巴细胞功能抑制的分子机制
  • 批准号:
    8243804
  • 财政年份:
    2012
  • 资助金额:
    $ 23.03万
  • 项目类别:
Regulation of B Lymphocyte Defects in Senescent Humans
衰老人类 B 淋巴细胞缺陷的调节
  • 批准号:
    8894635
  • 财政年份:
    2009
  • 资助金额:
    $ 23.03万
  • 项目类别:
Regulation of B Lymphocyte Defects in Senescent Humans
衰老人类 B 淋巴细胞缺陷的调节
  • 批准号:
    8132383
  • 财政年份:
    2009
  • 资助金额:
    $ 23.03万
  • 项目类别:
Regulation of B Lymphocyte Defects in Senescent Humans
衰老人类 B 淋巴细胞缺陷的调节
  • 批准号:
    8522102
  • 财政年份:
    2009
  • 资助金额:
    $ 23.03万
  • 项目类别:
Regulation of B Lymphocyte Defects in Senescent Humans
衰老人类 B 淋巴细胞缺陷的调节
  • 批准号:
    8309192
  • 财政年份:
    2009
  • 资助金额:
    $ 23.03万
  • 项目类别:
Regulation of B Lymphocyte Defects in Senescent Humans
衰老人类 B 淋巴细胞缺陷的调节
  • 批准号:
    7742557
  • 财政年份:
    2009
  • 资助金额:
    $ 23.03万
  • 项目类别:

相似海外基金

Potentials of Epigenetic Molecules in Attenuating the Phenotypes of Periodontitis
表观遗传分子减轻牙周炎表型的潜力
  • 批准号:
    10736171
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
R21 MPI microRNA 定向疗法治疗早期胰腺癌
  • 批准号:
    10577609
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
CRISPR-Cas Editing as a Genetic Cure for Autosomal Dominant Polycystic Kidney Disease
CRISPR-Cas 编辑作为常染色体显性多囊肾病的基因治疗
  • 批准号:
    10822502
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
Targeting specific MicroRNA to alleviate Alzheimer’s Disease pathobiology
靶向特定 MicroRNA 缓解阿尔茨海默病病理学
  • 批准号:
    10666871
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
Role of human apolipoprotein E isoforms in long-term effects of West Nile Virus exposure on Alzheimer's disease-related behavioral alteration, cognitive injury, neuroinflammation, and neuropathology
人类载脂蛋白 E 同工型在西尼罗河病毒暴露对阿尔茨海默病相关行为改变、认知损伤、神经炎症和神经病理学的长期影响中的作用
  • 批准号:
    10658408
  • 财政年份:
    2023
  • 资助金额:
    $ 23.03万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了